Discrimination between patients with activeLN and active non-LNMonitoring disease activity and response totherapyAccurately stratifying patients with regardsto extent and nature of renal injury without in vivo interventionInforming long-term prognosis
[Detail]
None
[Detail]
High efficiencyof labelingEnhancedcontrast
[Detail]
Revealing molecular-level signature of tumorLow cost, disposable, ease of mass productionMultifunctional diagnostic platform for different blood related diseases
[Detail]
| |< <- | [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] | -> >| |

